中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US07709524B2 Use of tellurium compounds for inhibition of interleukin-converting enzyme 失效
使用碲化合物抑制白介素转化酶

  • Patent Title: Use of tellurium compounds for inhibition of interleukin-converting enzyme
  • Patent Title (中): 使用碲化合物抑制白介素转化酶
  • Application No.: US11663032
    Application Date: 2005-09-15
  • Publication No.: US07709524B2
    Publication Date: 2010-05-04
  • Inventor: Michael Albeck , Benjamin Sredni
  • Applicant: Michael Albeck , Benjamin Sredni
  • Applicant Address: IL Kfar-Saba
  • Assignee: BioMAS Ltd.
  • Current Assignee: BioMAS Ltd.
  • Current Assignee Address: IL Kfar-Saba
  • International Application: PCT/IL2005/000990 WO 20050915
  • International Announcement: WO2006/030438 WO 20060323
  • Main IPC: A61K31/335
  • IPC: A61K31/335 ;  A61K31/28
Use of tellurium compounds for inhibition of interleukin-converting enzyme
Abstract:
Use of tellurium-containing compounds for treating conditions in which inhibition of caspase-1/interleukin-1β enzyme (ICE) is beneficial is disclosed.
Abstract(Chinese):

使用含碲化合物治疗其中抑制半胱天冬酶-1 /白介素-1和bgr的病症; 酶（ICE）是有益的。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0